Eligibility and cost for icosapent ethyl based on the reduce-it trial: Insight from the veterans affairs healthcare system

Xiaoming Jia, Julia M. Akeroyd, Khurram Nasir, Vijay Nambi, Christie M. Ballantyne, Laura A. Petersen, Salim S. Virani

Research output: Contribution to journal › Letter › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Eligibility and cost for icosapent ethyl based on the reduce-it trial: Insight from the veterans affairs healthcare system'. Together they form a unique fingerprint.